Keywords: seroquel, compliance, tops, competitors, treating, patients, first-episode
Seroquel compliance tops competitors
Article | 12 November 2001
Treating patients with first-episode schizophrenia and other psychoticdisorders with AstraZeneca's atypical antipyschotic Seroquel (quetiapine) leads to significantly better rates of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
